keyword
https://read.qxmd.com/read/38628610/comparison-of-periprocedural-and-procedure-room-times-between-moderate-sedation-and-monitored-anesthesia-care-in-interventional-radiology
#1
JOURNAL ARTICLE
Vlasios S Sotirchos, Erica S Alexander, Ken Zhao, Chenyang Zhan, Hooman Yarmohammadi, Etay Ziv, Joseph P Erinjeri
OBJECTIVES: In recent years, there has been increased utilization of monitored anesthesia care (MAC) in interventional radiology (IR) departments. The purpose of this study was to compare pre-procedure bed, procedure room, and post-procedure bed times for IR procedures performed with either nurse-administered moderate sedation (MOSED) or MAC. MATERIAL AND METHODS: An institutional review board-approved single institution retrospective review of IR procedures between January 2010 and September 2022 was performed...
2024: Journal of Clinical Imaging Science
https://read.qxmd.com/read/38621339/safety-and-efficacy-of-percutaneous-cryoablation-for-primary-and-metastatic-pleural-based-tumors
#2
JOURNAL ARTICLE
Erica S Alexander, Elena N Petre, Michael Offin, Marjorie Zauderer, Ken Zhao, Vlasios Sotirchos, Stephen B Solomon, Etay Ziv
PURPOSE: Assess safety and local tumor progression-free survival (LTPFS) of percutaneous cryoablation for pleural-based thoracic malignancies. MATERIALS AND METHODS: Retrospective study of 46 patients (17 treated for palliation; 9 for oligoprogression; 20 for curative intent), with 62 pleural-based thoracic lesions, treated in 59 cryoablation sessions. Patients were treated from 9/2005-11/2021 with CryoCare CS (Varian, Irvine, CA) or IceFORCE (Boston Scientific, Marlborough, MA) systems...
April 10, 2024: European Journal of Radiology
https://read.qxmd.com/read/38611685/imaging-considerations-before-and-after-liver-directed-locoregional-treatments-for-metastatic-colorectal-cancer
#3
REVIEW
David-Dimitris Chlorogiannis, Amgad M Moussa, Ken Zhao, Erica S Alexander, Constantinos T Sofocleous, Vlasios S Sotirchos
Colorectal cancer is a leading cause of cancer-related death. Liver metastases will develop in over one-third of patients with colorectal cancer and are a major cause of morbidity and mortality. Even though surgical resection has been considered the mainstay of treatment, only approximately 20% of the patients are surgical candidates. Liver-directed locoregional therapies such as thermal ablation, Yttrium-90 transarterial radioembolization, and stereotactic body radiation therapy are pivotal in managing colorectal liver metastatic disease...
April 5, 2024: Diagnostics
https://read.qxmd.com/read/38569875/validation-of-the-international-mogad-panel-proposed-criteria-a-single-centre-us-study
#4
JOURNAL ARTICLE
Angeliki G Filippatou, Yana Said, Haiwen Chen, Eleni S Vasileiou, Gelareh Ahmadi, Elias S Sotirchos
BACKGROUND: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a demyelinating disorder of the central nervous system. We aimed to evaluate the diagnostic performance of recently proposed MOGAD diagnostic criteria in a real-world patient cohort at a tertiary referral centre. METHODS: We identified all patients who were evaluated at Johns Hopkins and were MOG-IgG seropositive by cell-based assay. We retrospectively applied the proposed MOGAD diagnostic criteria...
April 3, 2024: Journal of Neurology, Neurosurgery, and Psychiatry
https://read.qxmd.com/read/38547435/acute-optic-neuropathy-in-older-adults-differentiating-between-mogad-optic-neuritis-and-nonarteritic-anterior-ischemic-optic-neuropathy
#5
MULTICENTER STUDY
Nanthaya Tisavipat, Hadas Stiebel-Kalish, Dahlia Palevski, Omer Y Bialer, Heather E Moss, Pareena Chaitanuwong, Tanyatuth Padungkiatsagul, Amanda D Henderson, Elias S Sotirchos, Shonar Singh, Abdul-Rahman Salman, Deena A Tajfirouz, Kevin D Chodnicki, Sean J Pittock, Eoin P Flanagan, John J Chen
BACKGROUND AND OBJECTIVES: Myelin oligodendrocyte glycoprotein antibody-associated disease optic neuritis (MOGAD-ON) and nonarteritic anterior ischemic optic neuropathy (NAION) can cause acute optic neuropathy in older adults but have different managements. We aimed to determine differentiating factors between MOGAD-ON and NAION and the frequency of serum MOG-IgG false positivity among patients with NAION. METHODS: In this international, multicenter, case-control study at tertiary neuro-ophthalmology centers, patients with MOGAD presenting with unilateral optic neuritis as their first attack at age 45 years or older and age-matched and sex-matched patients with NAION were included...
May 2024: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/38293182/bile-acid-metabolites-predict-multiple-sclerosis-progression-and-supplementation-is-safe-in-progressive-disease
#6
Dimitrios C Ladakis, Kimystian L Harrison, Matthew D Smith, Krista Solem, Sachin Gadani, Larissa Jank, Soonmyung Hwang, Farzaneh Farhadi, Blake E Dewey, Kathryn C Fitzgerald, Elias S Sotirchos, Shiv Saidha, Peter A Calabresi, Pavan Bhargava
BACKGROUND: Bile acid metabolism is altered in multiple sclerosis (MS) and tauroursodeoxycholic acid (TUDCA) supplementation ameliorated disease in mouse models of MS. METHODS: Global metabolomics was performed in an observational cohort of people with MS followed by pathway analysis to examine relationships between baseline metabolite levels and subsequent brain and retinal atrophy. A double-blind, placebo-controlled trial, was completed in people with progressive MS (PMS), randomized to receive either TUDCA (2g daily) or placebo for 16 weeks...
January 23, 2024: medRxiv
https://read.qxmd.com/read/38251887/a-noncanonical-cd56dimcd16dim-nk-cell-subset-indicative-of-prior-cytotoxic-activity-is-elevated-in-patients-with-autoantibody-mediated-neurologic-diseases
#7
JOURNAL ARTICLE
Soumya S Yandamuri, Beata Filipek, Nikhil Lele, Inessa Cohen, Jeffrey L Bennett, Richard J Nowak, Elias S Sotirchos, Erin E Longbrake, Emily M Mace, Kevin C O'Connor
Neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein Ab disease, and autoimmune myasthenia gravis (MG) are autoantibody-mediated neurologic conditions where autoantibodies can induce Ab-dependent cellular cytotoxicity (ADCC), a NK cell-mediated effector function. However, whether ADCC is a pathogenic mechanism in patients with these conditions has not been confirmed. We sought to characterize circulatory NK cells using functional assays, phenotyping, and transcriptomics to elucidate their role in pathology...
March 1, 2024: Journal of Immunology
https://read.qxmd.com/read/38215818/3d-margin-as-a-predictor-of-local-tumor-progression-after-microwave-ablation-intraprocedural-vs-4-8-week-post-ablation-assessment
#8
JOURNAL ARTICLE
Mahdi Zirakchian Zadeh, Vlasios S Sotirchos, Assen Kirov, Daniel Lafontaine, Mithat Gönen, Randy Yeh, Henry Kunin, Elena N Petre, Yuliya Kitsel, Mohammad Elsayed, Stephen B Solomon, Joseph P Erinjeri, Lawrence H Schwartz, Constantinos T Sofocleous
PURPOSE: To evaluate the prognostic accuracy of intra-procedural and 4-8-week (current standard) post-microwave ablation zone (AZ) and margin assessments for prediction of local tumor progression (LTP) using a 3D software. MATERIALS AND METHODS: One hundred colorectal liver metastases (CLMs) in 75 patients were collected from two prospective FDG PET/CT-guided microwave ablation (MWA) trials. The target CLMs and theoretical 5- and 10-mm margins were segmented and registered intra-procedurally and at the 4-8 weeks post-MWA CECT (or MRI) with the exact same methodology and 3D software...
January 10, 2024: Journal of Vascular and Interventional Radiology: JVIR
https://read.qxmd.com/read/38165314/rituximab-for-multiple-sclerosis-hiding-in-plain-sight
#9
JOURNAL ARTICLE
Annette Langer-Gould, Elias S Sotirchos, Dennis Bourdette
In February 2023, following extensive discussions with stakeholders and data review, the Institute for Clinical and Economic Review issued final policy recommendations for treatment of relapsing multiple sclerosis (RMS)1 : "All stakeholders have a responsibility and an important role to play in ensuring that all effective treatment options for patients with RMS, including off-label use of rituximab, are utilized in ways to help improve affordability and access and reduce health inequities." The report calls on payers to remove barriers to rituximab coverage, the American Academy of Neurology and the National MS Society to publicly endorse rituximab for RMS, and clinicians to advocate for coverage of rituximab and its biosimilars...
January 23, 2024: Neurology
https://read.qxmd.com/read/38136351/the-importance-of-optimal-thermal-ablation-margins-in-colorectal-liver-metastases-a-systematic-review-and-meta-analysis-of-21-studies
#10
REVIEW
David-Dimitris Chlorogiannis, Vlasios S Sotirchos, Christos Georgiades, Dimitrios Filippiadis, Ronald S Arellano, Mithat Gonen, Gregory C Makris, Tushar Garg, Constantinos T Sofocleous
BACKGROUND: Colorectal cancer (CRC) is the second most common cause of cancer-related deaths in the US. Thermal ablation (TA) can be a comparable alternative to partial hepatectomy for selected cases when eradication of all visible tumor with an ablative margin of greater than 5 mm is achieved. This systematic review and meta-analysis aimed to encapsulate the current clinical evidence concerning the optimal TA margin for local cure in patients with colorectal liver metastases (CLM). METHODS: MEDLINE, EMBASE, and the CENTRAL databases were systematically searched from inception until 1 May 2023, in accordance with the PRISMA Guidelines...
December 12, 2023: Cancers
https://read.qxmd.com/read/38088067/a-multicenter-pilot-study-evaluating-simplified-central-vein-assessment-for-the-diagnosis-of-multiple-sclerosis
#11
JOURNAL ARTICLE
Lynn Daboul, Carly M O'Donnell, Moein Amin, Paulo Rodrigues, John Derbyshire, Christina Azevedo, Amit Bar-Or, Eduardo Caverzasi, Peter A Calabresi, Bruce Ac Cree, Leorah Freeman, Roland G Henry, Erin E Longbrake, Jiwon Oh, Nico Papinutto, Daniel Pelletier, Vesna Prchkovska, Praneeta Raza, Marc Ramos, Rohini D Samudralwar, Matthew K Schindler, Elias S Sotirchos, Nancy L Sicotte, Andrew J Solomon, Russell T Shinohara, Daniel S Reich, Pascal Sati, Daniel Ontaneda
BACKGROUND: The central vein sign (CVS) is a proposed magnetic resonance imaging (MRI) biomarker for multiple sclerosis (MS); the optimal method for abbreviated CVS scoring is not yet established. OBJECTIVE: The aim of this study was to evaluate the performance of a simplified approach to CVS assessment in a multicenter study of patients being evaluated for suspected MS. METHODS: Adults referred for possible MS to 10 sites were recruited. A post-Gd 3D T2*-weighted MRI sequence (FLAIR*) was obtained in each subject...
December 13, 2023: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38018493/longitudinal-evaluation-of-serum-mog-igg-titers-in-mogad-after-initiation-of-maintenance-immunoglobulin-a-case-series
#12
JOURNAL ARTICLE
Shuvro Roy, Eleni Vasileiou, Paula Barreras, Gelareh Ahmadi, Haiwen Chen, William Suslovic, Alexandra Kornbluh, Ilana Kahn, Elias S Sotirchos
BACKGROUND: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a distinct demyelinating disease of the central nervous system. Immunoglobulin (Ig) has been used as a maintenance therapy to prevent relapses in MOGAD, but the impact of Ig on serum MOG-IgG titers is unclear. OBJECTIVE: To characterize the variation in serum MOG-IgG titers after initiation of Ig treatment in people with MOGAD. METHODS: We conducted a retrospective study of 10 patients with a diagnosis of MOGAD and available serum MOG-IgG titers before and after initiation of maintenance Ig treatment...
April 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/37958376/hepatic-hilar-block-as-an-adjunct-to-transarterial-embolization-of-neuroendocrine-tumors-a-retrospective-review-of-safety-and-efficacy
#13
JOURNAL ARTICLE
Samagra Jain, Harrison Blume, Lee Rodriguez, Elena Petre, Amgad Moussa, Ken Zhao, Vlasios Sotirchos, Nitya Raj, Diane Reidy, Etay Ziv, Erica Alexander
PURPOSE: This study investigates whether hepatic hilar nerve blocks (HHNB) provide safe, effective analgesia in patients with neuroendocrine tumors (NET) treated with transarterial embolization (TAE). METHODS: The retrospective study included all NETs treated with TAE or TAE + HHNB from 1/2020 to 8/2022. Eighty-five patients (45 men), mean age 62 years, were treated in 165 sessions (TAE, n = 153; TAE + HHNB, n = 12). For HHNBs, ≤10 mL bupivacaine HCl 0.25% ± 2 mg methylprednisolone were injected under ultrasound guidance...
October 29, 2023: Cancers
https://read.qxmd.com/read/37944085/percutaneous-image-guided-ablation-for-hepatic-metastases
#14
REVIEW
Vlasios S Sotirchos, Elena N Petre, Constantinos T Sofocleous
The presence of hepatic metastases indicates advanced disease and is associated with significant morbidity and mortality, especially when the hepatic disease is not amenable to locoregional treatments. The primary tumour of origin, the distribution and extent of metastatic disease, the underlying liver reserve, the patient performance status and the presence of comorbidities are factors that determine whether a patient will benefit from hepatectomy or local curative-intent treatments. For patients with metastatic colorectal cancer, the most common primary cancer that spreads to the liver, several studies have demonstrated a survival benefit for patients who can be treated with hepatectomy and/or percutaneous ablation, compared to those treated with chemotherapy alone...
November 9, 2023: Journal of Medical Imaging and Radiation Oncology
https://read.qxmd.com/read/37923172/yttrium-90-transarterial-radioembolization-of-primary-lung-cancer-metastases-to-the-liver
#15
JOURNAL ARTICLE
Erica S Alexander, Elena N Petre, Ken Zhao, Vlasios Sotirchos, Azadeh Namakydoust, Amgad Moussa, Gavin Yuan, Constantinos T Sofocleous, Stephen B Solomon, Etay Ziv
PURPOSE: To assess whether yttrium-90 transarterial radioembolization (TARE) is safe and effective in the treatment of primary lung cancer metastases to the liver (LCML). METHODS AND METHODS: This retrospective study included 57 patients with LCML who were treated with 79 TARE treatments. Histology included non-small cell lung cancer (NSCLC) (n = 27), small cell lung cancer (SCLC) (n = 17), and lung carcinoid (LC) (n = 13). Survival was calculated using Kaplan-Meier method; differences between groups were estimated using log rank test...
February 2024: Journal of Vascular and Interventional Radiology: JVIR
https://read.qxmd.com/read/37816633/agreement-between-published-reference-resources-for-neurofilament-light-chain-levels-in-people-with-multiple-sclerosis
#16
JOURNAL ARTICLE
Elias S Sotirchos, Chen Hu, Matthew D Smith, Hannah-Noelle Lord, Anna L DuVal, Georgina Arrambide, Xavier Montalban, Katja Akgün, Tjalf Ziemssen, Robert T Naismith, Carrie M Hersh, Megan Hyland, Lauren B Krupp, Jacqueline A Nicholas, Robert A Bermel, Ellen M Mowry, Peter A Calabresi, Kathryn C Fitzgerald
OBJECTIVES: To examine the agreement between published reference resources for neurofilament light chain (NfL) applied to a large population of people with multiple sclerosis (MS). METHODS: Six published reference resources were used to classify NfL in participants in the Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) network as elevated or normal and to derive age-specific NfL Z -scores. NfL values were classified as elevated if they exceeded the >95th percentile (i...
December 4, 2023: Neurology
https://read.qxmd.com/read/37460235/effects-of-ibudilast-on-retinal-atrophy-in-progressive-multiple-sclerosis-subtypes-post-hoc-analyses-of-the-sprint-ms-trial
#17
RANDOMIZED CONTROLLED TRIAL
Henrik Ehrhardt, Jeffrey Lambe, Hussein Moussa, Eleni S Vasileiou, Grigorios Kalaitzidis, Olwen C Murphy, Angeliki G Filippatou, Nicole Pellegrini, Morgan Douglas, Simidele Davis, Natalia Nagy, Agustina Quiroga, Chen Hu, Alexandra Zambriczki Lee, Anna Duval, Kathryn C Fitzgerald, Jerry L Prince, Peter A Calabresi, Elias S Sotirchos, Robert Bermel, Shiv Saidha
BACKGROUND AND OBJECTIVES: Ganglion cell + inner plexiform layer (GCIPL) thinning, measured by optical coherence tomography (OCT), reflects global neurodegeneration in multiple sclerosis (MS). Atrophy of the inner (INL) and outer nuclear layer (ONL) may also be prominent in progressive MS (PMS). The phase 2, SPRINT-MS trial found reduced brain atrophy with ibudilast therapy in PMS. In this post hoc analysis of the SPRINT-MS trial, we investigate (1) retinal atrophy (2) differences in response by subtype and (3) associations between OCT and MRI measures of neurodegeneration...
September 5, 2023: Neurology
https://read.qxmd.com/read/37428600/literature-commentary
#18
JOURNAL ARTICLE
(no author information available yet)
In this issue of JNO Drs. Mark L. Moster, Marc Dinkin, and Deborah I. Friedman discuss the following 6 articles: Thaller M, Homer V, Mollan SP, Sinclair AJ. Disease course and long-term outcomes in pregnant women with idiopathic intracranial hypertension: the IIH Prospective Maternal Health Study. Neurology. 2023. doi: 10.1212/WNL.0000000000206854. Epub ahead of print. PMID: 36750388.Chen JJ, Flanagan EP, Pittock SJ, Stern NC, Tisavipat N, Bhatti MT, Chodnicki KD, Tajfirouz DA, Jamali S, Kunchok A, Eggenberger ER, Nome MAD, Sotirchos ES, Vasileiou ES, Henderson AD, Arnold AC, Bonelli L, Moss HE, Navarro SEV, Padungkiatsagul T, Stiebel-Kalish H, Lotan I, Wilf-Yarkoni A, Danesh-Meyer H, Ivanov S, Huda S, Forcadela M, Hodge D, Poullin P, Rode J, Papeix C, Saheb S, Boudot de la Motte M, Vignal C, Hacohen Y, Pique J, Maillart E, Deschamps R, Audoin B, Marignier R...
July 10, 2023: Journal of Neuro-ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society
https://read.qxmd.com/read/37296356/the-effects-of-nly01-a-novel-glucagon-like-peptide-1-receptor-agonist-on-cuprizone-induced-demyelination-and-remyelination-challenges-and-future-perspectives
#19
JOURNAL ARTICLE
Marjan Gharagozloo, Danny Galleguillos, Larissa Jank, Elias S Sotirchos, Matthew D Smith, Thomas Garton, Swati Kumar, Omar Hussein, Saahith Potluri, Michelle Taylor, Catherine Siu, Jackson W Mace, Ted Dawson, Valina L Dawson, Seulki Lee, Peter A Calabresi
Recent evidence suggests that the glucagon-like peptide-1 receptor (GLP-1R) agonists have neuroprotective activities in the CNS in animal models of Parkinson's disease, Alzheimer's disease, and multiple sclerosis (MS). This study aimed to investigate whether a novel long-acting GLP-1R agonist, NLY01, could limit demyelination or improve remyelination as occurs in MS using the cuprizone (CPZ) mouse model. Herein, we assessed the expression of GLP-1R on oligodendrocytes in vitro and found that mature oligodendrocytes (Olig2+ PDGFRa- ) express GLP-1R...
June 9, 2023: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
https://read.qxmd.com/read/37268735/gradient-based-volumetric-pet-parameters-on-immediate-pre-ablation-fdg-pet%C3%A2-predict-local-tumor-progression-in-patients-with-colorectal-liver-metastasis-treated-by-microwave-ablation
#20
JOURNAL ARTICLE
Mahdi Zirakchian Zadeh, Randy Yeh, Assen S Kirov, Henry S Kunin, Mithat Gönen, Vlasios S Sotirchos, Kevin S Soares, Constantinos T Sofocleous
PURPOSE: This study aimed to evaluate the optimal method of segmentation of colorectal liver metastasis (CLM) on immediate pre-ablation PET scans and assess the prognostic value of quantitative pre-ablation PET parameters with regards to local tumor control. A secondary objective was to correlate the target tumor size estimation by PET methods with the tumor measurements on anatomical imaging. METHODOLOGY: A prospectively accrued cohort of 55 CLMs (46 patients) treated with real-time 18 F-FDG-PET/CT-guided percutaneous microwave ablation was followed-up for a median of 10...
June 2, 2023: Cardiovascular and Interventional Radiology
keyword
keyword
110146
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.